Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05713253 · ClinicalTrials.gov registry record · NA
A Phased, Prospective, Multi-center Study OF THE Elita System
A NA study, sponsored by Johnson & Johnson Surgical Vision.
- Terminated
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT05713253 is a NA study that was terminated before completion, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 96 participants.
The verdict
NCT05713253, a NA study, was terminated before completion, sponsored by Johnson & Johnson Surgical Vision.
- TERMINATED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study will be a 2-phase, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation to confirm the safety and effectiveness of the ELITA system.
Interventions
- DEVICE ELITA System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-02-02 |
| Est. Completion | 2025-02-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05713253
The ClinicalTrials.gov registry entry for NCT05713253 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Surgical Vision, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ELITA System is the first listed.
NCT05713253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05713253 about?
NCT05713253 is a clinical study titled "A Phased, Prospective, Multi-center Study OF THE Elita System". This study will be a 2-phase, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation to confirm the safety and effectiveness of the ELITA system.
What is the current status of trial NCT05713253?
This trial is currently terminated. It is a NA study. The enrollment target is 96 participants. The study started on 2023-02-02. Estimated completion is 2025-02-21.
What interventions are being tested in trial NCT05713253?
The interventions under investigation include: ELITA System (DEVICE).
Who is sponsoring clinical trial NCT05713253?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.